Cargando…

Chromosomal imbalance in the progression of high-risk non-muscle invasive bladder cancer

BACKGROUND: Non-muscle invasive bladder neoplasms with invasion of the lamina propria (stage T1) or high grade of dysplasia are at "high risk" of progression to life-threatening cancer. However, the individual course is difficult to predict. Chromosomal instability (CI) is associated with...

Descripción completa

Detalles Bibliográficos
Autores principales:	Zieger, Karsten, Wiuf, Carsten, Jensen, Klaus Møller-Ernst, Ørntoft, Torben Falck, Dyrskjøt, Lars
Formato:	Texto
Lenguaje:	English
Publicado:	BioMed Central 2009
Materias:	Research Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2696467/ https://www.ncbi.nlm.nih.gov/pubmed/19445696 http://dx.doi.org/10.1186/1471-2407-9-149

Ejemplares similares

Increased cell motility and invasion upon knockdown of lipolysis stimulated lipoprotein receptor (LSR) in SW780 bladder cancer cells
por: Herbsleb, Malene, et al.
Publicado: (2008)

Bioinformatic identification of FGF, p38-MAPK, and calcium signalling pathways associated with carcinoma in situ in the urinary bladder
por: Herbsleb, Malene, et al.
Publicado: (2008)

Prediction and diagnosis of bladder cancer recurrence based on urinary content of hTERT, SENP1, PPP1CA, and MCM5 transcripts
por: Brems-Eskildsen, Anne Sofie, et al.
Publicado: (2010)

High expression of GEM and EDNRA is associated with metastasis and poor outcome in patients with advanced bladder cancer
por: Laurberg, Jens Reumert, et al.
Publicado: (2014)

Risk Prediction Scores for Recurrence and Progression of Non-Muscle Invasive Bladder Cancer: An International Validation in Primary Tumours
por: Vedder, Moniek M., et al.
Publicado: (2014)

FOXM1 predicts disease progression in non-muscle invasive bladder cancer
por: Rinaldetti, Sebastien, et al.
Publicado: (2018)

High frequency of tumor cells with nuclear Egr-1 protein expression in human bladder cancer is associated with disease progression
por: Egerod, Frederikke Lihme, et al.
Publicado: (2009)

High miR-449b expression in prostate cancer is associated with biochemical recurrence after radical prostatectomy
por: Mortensen, Martin Mørck, et al.
Publicado: (2014)

Are microRNAs located in genomic regions associated with cancer?
por: Lamy, P, et al.
Publicado: (2006)

Diagnosis of Bladder Cancer Recurrence Based on Urinary Levels of EOMES, HOXA9, POU4F2, TWIST1, VIM, and ZNF154 Hypermethylation
por: Reinert, Thomas, et al.
Publicado: (2012)

Comprehensive multiregional analysis of molecular heterogeneity in bladder cancer
por: Thomsen, Mathilde Borg Houlberg, et al.
Publicado: (2017)

epiG: statistical inference and profiling of DNA methylation from whole-genome bisulfite sequencing data
por: Vincent, Martin, et al.
Publicado: (2017)

Expression profiling of prostate cancer tissue delineates genes associated with recurrence after prostatectomy
por: Mortensen, Martin Mørck, et al.
Publicado: (2015)

Genome-wide analysis of allelic imbalance in prostate cancer using the Affymetrix 50K SNP mapping array
por: Tørring, N, et al.
Publicado: (2007)

miRNAs associated with chemo-sensitivity in cell lines and in advanced bladder cancer
por: Nordentoft, Iver, et al.
Publicado: (2012)

A Hidden Markov Model to estimate population mixture and allelic copy-numbers in cancers using Affymetrix SNP arrays
por: Lamy, Philippe, et al.
Publicado: (2007)

Increased expression of transcription factor TFAP2α correlates with chemosensitivity in advanced bladder cancer
por: Nordentoft, Iver, et al.
Publicado: (2011)

Next-generation sequencing identifies germline MRE11A variants as markers of radiotherapy outcomes in muscle-invasive bladder cancer
por: Teo, M. T. W., et al.
Publicado: (2014)

Profiling of long non-coding RNAs identifies LINC00958 and LINC01296 as candidate oncogenes in bladder cancer
por: Seitz, Anna Katharina, et al.
Publicado: (2017)

Molecular correlates of cisplatin-based chemotherapy response in muscle invasive bladder cancer by integrated multi-omics analysis
por: Taber, Ann, et al.
Publicado: (2020)

Expression of MAGE-A3, NY-ESO-1, LAGE-1 and PRAME in urothelial carcinoma
por: Dyrskjøt, L, et al.
Publicado: (2012)

Author Correction: Molecular correlates of cisplatin-based chemotherapy response in muscle invasive bladder cancer by integrated multi-omics analysis
por: Taber, Ann, et al.
Publicado: (2022)

Evaluation of two commercial global miRNA expression profiling platforms for detection of less abundant miRNAs
por: Jensen, Steffen G, et al.
Publicado: (2011)

A Beta-mixture model for dimensionality reduction, sample classification and analysis
por: Laurila, Kirsti, et al.
Publicado: (2011)

Collagen stiffness promoted non-muscle-invasive bladder cancer progression to muscle-invasive bladder cancer
por: Zhu, Huier, et al.
Publicado: (2019)

SPTAN1, APC, and FGFR3 Mutation Status and APOBEC Mutation Signatures are Predictive of Mitomycin C Response in Non-muscle-invasive Bladder Cancer
por: Lindgren, Maria Skydt, et al.
Publicado: (2021)

Analysis of molecular intra-patient variation and delineation of a prognostic 12-gene signature in non-muscle invasive bladder cancer; technology transfer from microarrays to PCR
por: Dyrskjøt, L, et al.
Publicado: (2012)

Selection of Microsatellite Markers for Bladder Cancer Diagnosis without the Need for Corresponding Blood
por: van Tilborg, Angela A. G., et al.
Publicado: (2012)

Tumor-specific usage of alternative transcription start sites in colorectal cancer identified by genome-wide exon array analysis
por: Thorsen, Kasper, et al.
Publicado: (2011)

MALBAC-based chromosomal imbalance analysis: a novel technique enabling effective non-invasive diagnosis and monitoring of bladder cancer
por: Liu, Hao, et al.
Publicado: (2018)

Cell-Free Urine and Plasma DNA Mutational Analysis Predicts Neoadjuvant Chemotherapy Response and Outcome in Patients with Muscle-Invasive Bladder Cancer
por: Christensen, Emil, et al.
Publicado: (2023)

The miR-143/-145 cluster regulates plasminogen activator inhibitor-1 in bladder cancer
por: Villadsen, S B, et al.
Publicado: (2012)

Classifying cGAS-STING Activity Links Chromosomal Instability with Immunotherapy Response in Metastatic Bladder Cancer
por: Sokač, Mateo, et al.
Publicado: (2022)

A Consensus Molecular Classification of Muscle-invasive Bladder Cancer
por: Kamoun, Aurélie, et al.
Publicado: (2019)

Gene expression profiling of noninvasive primary urothelial tumours using microarrays
por: Aaboe, M, et al.
Publicado: (2005)

Chromosomal imbalances are uncommon in chagasic megaesophagus
por: Bellini, Marilanda F, et al.
Publicado: (2010)

Novel diagnostic and prognostic classifiers for prostate cancer identified by genome-wide microRNA profiling
por: Kristensen, Helle, et al.
Publicado: (2016)

Loss of heterozygosity on chromosome 18q is associated with muscle-invasive transitional cell carcinoma of the bladder.
por: Brewster, S. F., et al.
Publicado: (1994)

Bladder Preservation for Muscle Invasive Bladder Cancer
por: Mirza, Arafat, et al.
Publicado: (2016)

Submicroscopic chromosomal imbalances contribute to early abortion
por: Li, Haibo, et al.
Publicado: (2018)

Cannot write session to /tmp/vufind_sessions/sess_m301qer049fv21eqt33uohmh2f